{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:06:26Z","timestamp":1793826386302,"version":"4.6.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There has been an increase in Acute Coronary Syndrome (ACS) patients without standard modifiable risk factors i.e. hypertension, diabetes, dyslipidemia, and tobacco use (SMuRFless) compared to the patients with \u2265\u20091 SMuRF but this has not been studied in South Asia despite them being a high-risk population. We conducted a comparative analysis of first episodes of ACS cases admitted to a tertiary cardiac center in Pakistan between SMuRFless and \u2265\u20091 SMuRF patients for clinical presentation, management, in-hospital, and 5-year mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We undertook a retrospective study and data of 15,051 patients admitted at Tabba Heart Institute (THI) with the first episode of ACS was extracted from Chest Pain-MI\u2122, and the CathPCI Registry\u00ae registry affiliated with the National Cardiovascular Data Registry (NCDR\u00ae), USA. Logistic regression and Cox proportional algorithm yielded odds ratio (OR) and hazard ratios (HR) with 95% confidence interval (CI) for associated factors of in-patient and 5-year mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 15% SMuRFless cases and in-hospital mortality was 4.1% in SMuRFless vs. 3.9% in the \u2265\u20091 SMuRF group (p-0.59), the difference remained insignificant after adjusting for age, gender, Killip class, multivessel disease, type of ACS, percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) (Adjusted OR:1.1 [0.8, 1.3]. Unadjusted 5-year mortality was 40% lower in the SMuRFless group but the difference was insignificant after adjusting for age, gender, disease at presentation, its severity, and management (Adjusted HR 0.7 95% CI[0.5, 1.0]). STEMI, NSTEMI, Killip class, and multivessel disease increased the risk of overall 5-year mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In-hospital and 5-year mortality was not different between the SMuRFless and \u2265\u20091 SMuRF group, there is a need to understand mediators of immediate and long-term mortality risk in SMuRFless patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03355-z","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T13:03:27Z","timestamp":1687611807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical characteristics, management, and 5-year survival compared between no standard modifiable risk factor (SMuRFless) and \u2265\u20091 SMuRF ACS cases: an analysis of 15,051 cases from Pakistan"],"prefix":"10.1186","volume":"23","author":[{"given":"Sana","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Peerwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"issue":"23","key":"3355_CR1","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1161\/hc4701.099488","volume":"104","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Reddy S, \u00d4unpuu S, Anand S. Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23):2855\u201364.","journal-title":"Circulation"},{"issue":"9438","key":"3355_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet. 2004;364(9438):937\u201352.","journal-title":"The lancet"},{"issue":"Suppl C","key":"3355_CR3","first-page":"226C","volume":"17","author":"M Gupta","year":"2001","unstructured":"Gupta M, Singh N, Warsi M, Reiter M, Ali K. Canadian South Asians have more severe angiographic coronary disease than european Canadians despite having fewer risk factors. Can J Cardiol. 2001;17(Suppl C):226\u00a0C.","journal-title":"Can J Cardiol"},{"issue":"21","key":"3355_CR4","doi-asserted-by":"publisher","first-page":"e013296","DOI":"10.1161\/JAHA.119.013296","volume":"8","author":"ST Vernon","year":"2019","unstructured":"Vernon ST, Coffey S, D\u2019Souza M, Chow CK, Kilian J, Hyun K, et al. ST-Segment\u2013elevation myocardial infarction (STEMI) patients without Standard Modifiable Cardiovascular risk factors\u2014how common are they, and what are their outcomes? J Am Heart Association. 2019;8(21):e013296.","journal-title":"J Am Heart Association"},{"issue":"10279","key":"3355_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(21)00272-5","volume":"397","author":"GA Figtree","year":"2021","unstructured":"Figtree GA, Vernon ST, Hadziosmanovic N, Sundstr\u00f6m J, Alfredsson J, Arnott C, et al. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. The Lancet. 2021;397(10279):1085\u201394.","journal-title":"The Lancet"},{"issue":"4","key":"3355_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11239-022-02704-7","volume":"54","author":"G Kong","year":"2022","unstructured":"Kong G, Chew NW, Ng CH, Chin YH, Zeng R, Foo R, et al. Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study of 5400 asian patients. J Thromb Thrombolysis. 2022;54(4):569\u201378.","journal-title":"J Thromb Thrombolysis"},{"key":"3355_CR7","doi-asserted-by":"crossref","unstructured":"Sia C-H, Ko J, Zheng H, Ho AF-W, Foo D, Foo L-L et al. Comparison of mortality outcomes in Acute myocardial infarction patients with or without Standard Modifiable Cardiovascular Risk factors. Front Cardiovasc Med. 2022;9.","DOI":"10.3389\/fcvm.2022.876465"},{"key":"3355_CR8","unstructured":"National Health Vision. Pakistan 2016\u20132025. 2016."},{"issue":"4","key":"3355_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/09638237.2018.1521919","volume":"28","author":"A Khalid","year":"2019","unstructured":"Khalid A, Qadir F, Chan SWY, Schwannauer M. Adolescents\u2019 mental health and well-being in developing countries: a cross-sectional survey from Pakistan. J Ment Health. 2019;28(4):389\u201396.","journal-title":"J Ment Health"},{"key":"3355_CR10","unstructured":"NCDR CathPCI. registry v5.0 coder\u2019s data dictionary. American College of Cardiology; 2019."},{"issue":"7","key":"3355_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/eurjpc\/zwab200","volume":"29","author":"SM Moledina","year":"2021","unstructured":"Moledina SM, Rashid M, Nolan J, Nakao K, Sun LY, Velagapudi P, et al. Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study. Eur J Prev Cardiol. 2021;29(7):1084\u201392.","journal-title":"Eur J Prev Cardiol"},{"issue":"18Supplement1","key":"3355_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0735-1097(21)01569-2","volume":"77","author":"JP Gnanaraj","year":"2021","unstructured":"Gnanaraj JP, Iliyas M, Sethupathy S, Saravanan SS, Kurian S, Srinivas S, et al. The Neglected Population of Stemi without Standard Modifiable Cardiovascular Risk factors. Insights from a prospective single centre Stemi Registry. J Am Coll Cardiol. 2021;77(18Supplement1):210.","journal-title":"J Am Coll Cardiol"},{"key":"3355_CR13","unstructured":"Bloomberg\u2019s Global Health Index. 2020: Johns Hopkins Bloomberg School of Public Health; 2020 [cited 23 November 2022 23 November 2022]. Available from: https:\/\/worldhealth.net\/news\/bloombergs-global-health-index-2020\/."},{"key":"3355_CR14","doi-asserted-by":"crossref","unstructured":"Weight N, Moledina S, Dafaalla M, Mamas MA, Group KCR. Ethnic disparities in ST-segment myocardial infarction outcomes and processes of care in patients with and without standard modifiable cardiovascular risk factors: a nationwide cohort study. Eur Heart J. 2022;43(Supplement_2).","DOI":"10.1093\/eurheartj\/ehac544.1179"},{"key":"3355_CR15","doi-asserted-by":"publisher","first-page":"869168","DOI":"10.3389\/fcvm.2022.869168","volume":"9","author":"G Kong","year":"2022","unstructured":"Kong G, Chew NWS, Ng CH, Chin YH, Lim OZH, Ambhore A, et al. Prognostic outcomes in Acute myocardial infarction patients without standard modifiable risk factors: a multiethnic study of 8,680 asian patients. Front Cardiovasc Med. 2022;9:869168.","journal-title":"Front Cardiovasc Med"},{"issue":"15","key":"3355_CR16","doi-asserted-by":"publisher","first-page":"e024818","DOI":"10.1161\/JAHA.121.024818","volume":"11","author":"GA Figtree","year":"2022","unstructured":"Figtree GA, Vernon ST, Hadziosmanovic N, Sundstr\u00f6m J, Alfredsson J, Nicholls SJ, et al. Mortality and Cardiovascular Outcomes in patients presenting with Non\u2013ST Elevation Myocardial Infarction despite no standard modifiable risk factors: results from the SWEDEHEART Registry. J Am Heart Association. 2022;11(15):e024818.","journal-title":"J Am Heart Association"},{"key":"3355_CR17","doi-asserted-by":"publisher","first-page":"876465","DOI":"10.3389\/fcvm.2022.876465","volume":"9","author":"CH Sia","year":"2022","unstructured":"Sia CH, Ko J, Zheng H, Ho AF, Foo D, Foo LL, et al. Comparison of mortality outcomes in Acute myocardial infarction patients with or without Standard Modifiable Cardiovascular Risk factors. Front Cardiovasc Med. 2022;9:876465.","journal-title":"Front Cardiovasc Med"},{"key":"3355_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.amjcard.2021.10.032","volume":"164","author":"K Yamamoto","year":"2022","unstructured":"Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Takeji Y, Yamaji K, et al. Coronary artery disease without Standard Cardiovascular Risk factors. Am J Cardiol. 2022;164:34\u201343.","journal-title":"Am J Cardiol"},{"issue":"1","key":"3355_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11883-018-0706-1","volume":"20","author":"ST Ahmed","year":"2018","unstructured":"Ahmed ST, Rehman H, Akeroyd JM, Alam M, Shah T, Kalra A, et al. Premature Coronary Heart Disease in South Asians: Burden and Determinants. Curr Atheroscler Rep. 2018;20(1):6.","journal-title":"Curr Atheroscler Rep"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03355-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03355-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03355-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T13:05:48Z","timestamp":1687611948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03355-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3355"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03355-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirmed that all methods were carried out in accordance with relevant guidelines and regulations. Ethical approval was taken from Institutional Review Board of Tabba Heart Institute (OHRP Reg# IORG0007863) that granted the exemption for consent taking as data was taken from the registry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"320"}}